Site search

Clear filter
2956 results for '' found
A Phase 2, Multicenter, Randomized, Open-label Trial to Evaluate Safety and Efficacy of Two Dose Levels of Quizartinib as Maintenance for Adult Patients with Newly Diagnosed FLT3-ITD + Acute M
A Phase 2, Multicenter, Randomized, Open-label Trial to Evaluate Safety and Efficacy of Two Dose Levels of Quizartinib as Maintenance for Adult Patients with Newly Diagnosed FLT3-ITD + Acute M
/
Alfred Mental & Addiction Health Cultural Safety, Equity and Access Strategic Direction 2026-2028 pdf
AMAH_CSEA_Strategy_Direction_2026-2028_Digital.pdf
Transition Care Program Guide pdf
Transition_Care_Program_Guide.pdf
Transition Care Program - Client Service Agreement pdf
Transition_Care_Program_Client_Service_Agreement.pdf
Minderoo Foundation Wellness Centre - Newsletter May 2026 pdf
Wellness_Centre_Newsletter_May_2026.pdf
Clinical Trials and Research Ethics Applications page
https://www.clinicaltrialsandresearch.vic.gov.au/ethics-application
Alfred Health - Bariatric surgery and medications PDF
https://app.prompt.org.au/download/262643?code=221a80cb-7815-492b-abd8-fe954d16edd6
The Alfred - Cardiac Care at Home PDF
https://app.prompt.org.au/download/262288?code=27ce0a0c-3eb0-4d7e-99bb-ee57ee71e004
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess Efficacy and Safety of Zasocitinib in Moderate to Severe Hidradenitis Suppurativa (NCT07244263)
/
Repeat Ablation of Persistent Atrial Fibrillation, including Mitral Isthmus and Cavo-Tricuspid Isthmus Ablations, with the FARAPULSE Pulsed Field Ablation System 〈NCT06735534〉
/
6 7 8 9 10